News – Page 523 – Endpoints News

Amylyx's ALS drug gets a three-month PDUFA delay, setting up the pivotal decision for September

4 years ago

Bristol Myers jumps into the M&A game with a $4B oncology buyout. And weary biotech analysts couldn't be any happier

4 years ago

Days after disclosing trial flop, stem cell therapy developer axes 70% of workforce while searching for cash

4 years ago

All in on early-stage, Qiming US bags $260M, recruits Atara founder Isaac Ciechanover for Fund III

4 years ago

Time Passages: Bruce Goldsmith out at Jim Wilson's gene therapy biotech; Flagship reveals Michael Severino’s CEO ...

4 years ago

Regeneron inks $1B+ deal for global rights to Sanofi-partnered PD-1 Libtayo

4 years ago

Pfizer, like Moderna, fires back at Alnylam suit over Covid-19 vaccine patents

4 years ago

Novartis resumes remote business in Ukraine after safety protocol review

4 years ago

Another refuse-to-file for a small biotech — is the FDA using RTFs to manage its workload?

4 years ago

Organon debuts murals created by women around the world, plus ambitious ESG plan, on first anniversary

4 years ago

Gilead poaches new pharma development and manufacturing chief from cell therapy 2.0 player

4 years ago

FDA compliance vet heads to India-based Lupin after long public career

4 years ago

Manufacturing roundup: Lonza collaborates with a VC in Israel; Piramal updates one facility while opening a new one

4 years ago

The target is the system: Condensates biotech aspires to ‘rewrite the rulebook’ on drug discovery

4 years ago

Biogen, Samsung Bioepis look to carve up a blockbuster Roche franchise with deep discount biosimilar

4 years ago

Civica nabs trial partner as it forges ahead to create more affordable insulins

4 years ago

Centessa axes lead program after a patient in kidney disease safety study is hospitalized

4 years ago

After filing for bankruptcy, rejected migraine drug developer Zosano’s value more than halved

4 years ago

Santhera renegotiates milestone payment, increases liquidity runway into 2023 pending NDA filing

4 years ago

Immatics imagines broader CAR-T pipeline with another Bristol Myers pact and addition to 2019 TCR deal

4 years ago

Evonik to make a multimillion-dollar investment at their Indiana site

4 years ago

Cambrex secures acquisition in Ireland, increasing their European footprint

4 years ago

Sana banks on $100M savings as it shifts manufacturing plans to Washington state

4 years ago

Precision drug + diagnostics biotech scores modest Series A, retrofitting existing drug for new indication

4 years ago

First page Previous page 520 521 522523524 525 526 Next page Last page